GLUE
Monte Rosa Therapeutics, Inc. Common Stock
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Best Biotech Stocks 2026 →
Monte Rosa Therapeutics (GLUE) Stock: Buy, Sell, or Hold?
$10.31
-0.19 (-1.81%)
âŧ
5d:
-4.71%
30d:
+4.25%
90d:
-34.91%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Nov 05, 2026
0d
Protect GLUE Gains
Updated Nov 11, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (75%)
Quality Score
43/100
Position
FAIR
30-Day Fair Range
$10.10 â $10.90
Position: FAIR
Forward P/E & Valuation
-5.8x
Next 12M consensus est.
Wall Street Target
$25.38
+146.1% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$9.88 / $11.20
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: GLUE is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
Get Alerted When GLUE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: GLUE is currently trading at $10.31, which is considered fair relative to its 30-day fair value range of $10.10 to $10.90.
Technical Outlook: Technically, GLUE is in a strong downtrend. Immediate support is located at $9.88, while resistance sits at $11.20.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $25.38 (+146.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, GLUE is in a strong downtrend. Immediate support is located at $9.88, while resistance sits at $11.20.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $25.38 (+146.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$10.10 -
$10.90
Company Quality Score
43/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.7%
Trading Range & Key Levels
30-Day Trading Range
$10.10 -
$10.90
Current vs Trading Range
FAIR
Support Level
$9.88
Resistance Level
$11.20
Current Trend
Strong Downtrend
Technical data as of
Nov 11, 2026
Protect Your Profits
Holding GLUE? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 146.1% below Wall St target ($25.38)
- WARNING: Composite score 42/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-5.81
Wall Street Target
$25.38
(+146.1%)
Revenue Growth (YoY)
325.8%
Profit Margin
-186.2%
Share GLUE Analysis
Share this live GLUE analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (GLUE)
Bullish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Oct 19, 2026
Daily AI digest
AI Retail Discussion Summary:
A bullish trader on StockTwits expresses optimism towards $GLUE stock, awaiting Q3 earnings announcement for clarity on certain regulatory matters.
Key Retail Themes:
earnings announcement
regulatory clarity
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 3:34 AM ET
Data refreshes hourly during market hours. Next update: 4:34 AM
Data refreshes hourly during market hours. Next update: 4:34 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GLUE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
20 analysts |
$36 | 49 HOLD |
|
WVE
Wave Life Sciences Ltd |
STRONG BUY
21 analysts |
$17 | 34 SELL |
|
NAMS
NewAmsterdam Pharma CompâĻ |
STRONG BUY
16 analysts |
$50 | 44 HOLD |
|
SRRK
Scholar Rock Holding Corp |
STRONG BUY
18 analysts |
$70 | 32 SELL |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
14 analysts |
$34 | 52 HOLD |
Advanced GLUE Option Strategies
Professional options setups generated by AI based on today's GLUE price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive GLUE Research Pages
